Taylor North1,2, Alexander Cheong3,4, Paul Steinbok3,4, Julia Ae Radic3,4. 1. University of British Columbia, Vancouver, BC, Canada. taylor.north@alumni.ubc.ca. 2. Division of Pediatric Neurosurgery, British Columbia Children's Hospital (BCCH), 4480 Oak Street, Rm K3-167, Vancouver, BC, V6H 3V4, Canada. taylor.north@alumni.ubc.ca. 3. University of British Columbia, Vancouver, BC, Canada. 4. Division of Pediatric Neurosurgery, British Columbia Children's Hospital (BCCH), 4480 Oak Street, Rm K3-167, Vancouver, BC, V6H 3V4, Canada.
Abstract
PURPOSE: Myelomeningocele is typically a disabling condition that results in neurologic, orthopedic, and urologic morbidity. The aim of this study was to examine the trends over time in both incidence and outcomes of myelomeningocele (MMC) in British Columbia (BC). METHODS: A retrospective chart review was performed of all children with MMC followed in the British Columbia Children's Hospital (BCCH) Spinal Cord Clinic between 1971 and 2016. The incidence of new MMC cases and the long-term outcomes of MMC were compared between two 10-year cohorts. The first cohort comprised children born with MMC between 1971 and 1981, and the second cohort comprised children born with MMC between 1996 and 2006. RESULTS: A total of 309 children with MMC were followed in the BCCH Spinal Cord Clinic between 1971 and 2016. There were 101 and 46 children with MMC in the two-time cohorts, respectively. Between the earlier and later cohorts, there was a significant difference in the following: MMC incidence [2.5/10,000 births vs 1.1/10,000 births, respectively (p = 0.0002)], mortality [18 vs 0% (p = 0.0009)], and the proportion of cases repaired in under 48 h [56 vs 98% (p < 0.0001)]. For surviving children, the proportion of children attending special classes was significantly different between the earlier and later cohorts [16 vs 46%, respectively (p = 0.0002)], whereas all other outcome measures, including the proportion with hydrocephalus, kyphoscoliosis, Chiari II surgery, bowel and bladder continence, recreation participation, obesity, and ambulation, were not significantly different. CONCLUSIONS: In BC, the incidence of new cases of MMC has decreased between 1971 and 2016, while the probability of survival for these patients has increased. Despite earlier and more universal post-natal repair, long-term outcomes have not improved significantly over time. Future research should focus on developing ways of reducing disability and improving quality of life for MMC patients and their families.
PURPOSE: Myelomeningocele is typically a disabling condition that results in neurologic, orthopedic, and urologic morbidity. The aim of this study was to examine the trends over time in both incidence and outcomes of myelomeningocele (MMC) in British Columbia (BC). METHODS: A retrospective chart review was performed of all children with MMC followed in the British ColumbiaChildren's Hospital (BCCH) Spinal Cord Clinic between 1971 and 2016. The incidence of new MMC cases and the long-term outcomes of MMC were compared between two 10-year cohorts. The first cohort comprised children born with MMC between 1971 and 1981, and the second cohort comprised children born with MMC between 1996 and 2006. RESULTS: A total of 309 children with MMC were followed in the BCCH Spinal Cord Clinic between 1971 and 2016. There were 101 and 46 children with MMC in the two-time cohorts, respectively. Between the earlier and later cohorts, there was a significant difference in the following: MMC incidence [2.5/10,000 births vs 1.1/10,000 births, respectively (p = 0.0002)], mortality [18 vs 0% (p = 0.0009)], and the proportion of cases repaired in under 48 h [56 vs 98% (p < 0.0001)]. For surviving children, the proportion of children attending special classes was significantly different between the earlier and later cohorts [16 vs 46%, respectively (p = 0.0002)], whereas all other outcome measures, including the proportion with hydrocephalus, kyphoscoliosis, Chiari II surgery, bowel and bladder continence, recreation participation, obesity, and ambulation, were not significantly different. CONCLUSIONS: In BC, the incidence of new cases of MMC has decreased between 1971 and 2016, while the probability of survival for these patients has increased. Despite earlier and more universal post-natal repair, long-term outcomes have not improved significantly over time. Future research should focus on developing ways of reducing disability and improving quality of life for MMC patients and their families.
Authors: Margot I Van Allen; Erin Boyle; Paul Thiessen; Deborah McFadden; Douglas Cochrane; G Keith Chambers; Sylvie Langlois; Patricia Stathers; Beverly Irwin; Elizabeth Cairns; Patrick MacLeod; Marie-France Delisle; Soo-Hong Uh Journal: J Appl Genet Date: 2006 Impact factor: 3.240
Authors: Ryan M Antiel; Alan W Flake; Mark P Johnson; Nahla Khalek; Natalie E Rintoul; John D Lantos; Farr A Curlin; Jon C Tilburt; Chris Feudtner Journal: Fetal Diagn Ther Date: 2017-03-17 Impact factor: 2.587
Authors: Matthew C Davis; Betsy D Hopson; Jeffrey P Blount; Rachel Carroll; Tracey S Wilson; Danielle K Powell; Amie B Jackson McLain; Brandon G Rocque Journal: J Neurosurg Spine Date: 2017-05-26
Authors: Philippe De Wals; Fassiatou Tairou; Margot I Van Allen; Soo-Hong Uh; R Brian Lowry; Barbara Sibbald; Jane A Evans; Michiel C Van den Hof; Pamela Zimmer; Marian Crowley; Bridget Fernandez; Nora S Lee; Theophile Niyonsenga Journal: N Engl J Med Date: 2007-07-12 Impact factor: 91.245
Authors: Marian K Bakker; Vijaya Kancherla; Mark A Canfield; Eva Bermejo-Sanchez; Janet D Cragan; Saeed Dastgiri; Hermien E K De Walle; Marcia L Feldkamp; Boris Groisman; Miriam Gatt; Paula Hurtado-Villa; Karin Kallen; Daniella Landau; Nathalie Lelong; Jorge S Lopez Camelo; Laura Martínez; Margery Morgan; Osvaldo M Mutchinick; Wendy N Nembhard; Anna Pierini; Anke Rissmann; Antonin Sipek; Elena Szabova; Giovanna Tagliabue; Wladimir Wertelecki; Ignacio Zarante; Pierpaolo Mastroiacovo Journal: Paediatr Perinat Epidemiol Date: 2019-10-21 Impact factor: 3.980
Authors: Samar Altoukhi; Clare L Whitehead; Greg Ryan; Jan Deprest; Luc Joyeux; Katie Gallagher; James Drake; Paige Church; Daphne Horn; Yenge Diambomba; Jose C A Carvalho; Tim Van Mieghem Journal: Trials Date: 2020-08-21 Impact factor: 2.279